Difference between revisions of "Part:BBa K3733008"

 
Line 3: Line 3:
 
<partinfo>BBa_K3733008 short</partinfo>
 
<partinfo>BBa_K3733008 short</partinfo>
  
LL-37 and LTA are both affective antimicrobial peptides (AMPs). HyL&#945; successfully combine those two AMPs by connecting the C-terminate of LTA with the N-terminate of LL-37 through GC-linker. It could neutralize Lipopolysaccharides (LPS), thus effectively blocking the downstream inflammation pathway.
+
LL-37 and LTA are both affective antimicrobial peptides (AMPs). HyL&#945; successfully combine those two AMPs by connecting the C-terminate of LTA with the N-terminate of LL-37 through GS-linker. It could neutralize Lipopolysaccharides (LPS), thus effectively blocking the downstream inflammation pathway.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Revision as of 13:01, 28 September 2021


HyLα: Hybrid peptide of LL-37 and LTA

LL-37 and LTA are both affective antimicrobial peptides (AMPs). HyLα successfully combine those two AMPs by connecting the C-terminate of LTA with the N-terminate of LL-37 through GS-linker. It could neutralize Lipopolysaccharides (LPS), thus effectively blocking the downstream inflammation pathway.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]